Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Hepatitis B and pertussis antibodies in 4- to 5-year-old children previously vaccinated with different hexavalent vaccines.

Vesikari T, Xu J, Johnson DR, Hall J, Marček T, Goveia MG, Acosta CJ, Lee AW.

Hum Vaccin Immunother. 2019 Nov 5:1-8. doi: 10.1080/21645515.2019.1673119. [Epub ahead of print]

PMID:
31689166
2.

Correction to: Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach.

Hayajneh WA, Daniels VJ, James CK, Kanıbir MN, Pilsbury M, Marks M, Goveia MG, Elbasha EH, Dasbach E, Acosta CJ.

BMC Infect Dis. 2019 Oct 28;19(1):904. doi: 10.1186/s12879-019-4533-y.

3.

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults.

Stacey HL, Rosen J, Peterson JT, Williams-Diaz A, Gakhar V, Sterling TM, Acosta CJ, Nolan KM, Li J, Pedley A, Benner P, Abeygunawardana C, Kosinski M, Smith WJ, Pujar H, Musey LK.

Hum Vaccin Immunother. 2019;15(3):530-539. doi: 10.1080/21645515.2018.1532249. Epub 2019 Jan 16.

PMID:
30648919
4.

Impact of Out-of-Pocket Cost on Herpes Zoster Vaccine Uptake: An Observational Study in a Medicare Managed Care Population.

Tao Z, Li Y, Stemkowski S, Johnson KD, Acosta CJ, Zhang D, Fendrick AM.

Vaccines (Basel). 2018 Nov 21;6(4). pii: E78. doi: 10.3390/vaccines6040078.

5.

Safety and immunogenicity of VAQTA® in children 12-to-23 months of age with and without administration of other US pediatric vaccines.

Petrecz M, Acosta CJ, Klopfer SO, Kuter BJ, Goveia MG, Stek JE, Schödel FP, Lee AW.

Hum Vaccin Immunother. 2019;15(2):426-432. doi: 10.1080/21645515.2018.1530934. Epub 2018 Nov 15.

PMID:
30431383
6.

A cross-sectional survey of work and income loss consideration among patients with herpes zoster when completing a quality of life questionnaire.

Johnson KD, Brenneman SK, Newransky C, Sheffler-Collins S, Becker LK, Belland A, Acosta CJ.

BMC Health Serv Res. 2018 Aug 25;18(1):662. doi: 10.1186/s12913-018-3451-9.

7.

Measuring herpes zoster disease burden in São Paulo, Brazil: a clinico-epidemiological single-center study.

Toniolo-Neto J, Psaradellis E, Karellis A, Rampakakis E, Rockett TY, Sampalis JS, Johnson KD, Monsanto HA, Acosta CJ.

Clinics (Sao Paulo). 2018 Jul 19;73:e243. doi: 10.6061/clinics/2018/e243.

8.

SliC is a surface-displayed lipoprotein that is required for the anti-lysozyme strategy during Neisseria gonorrhoeae infection.

Zielke RA, Le Van A, Baarda BI, Herrera MF, Acosta CJ, Jerse AE, Sikora AE.

PLoS Pathog. 2018 Jul 5;14(7):e1007081. doi: 10.1371/journal.ppat.1007081. eCollection 2018 Jul.

9.

Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach.

Hayajneh WA, Daniels VJ, James CK, Kanıbir MN, Pilsbury M, Marks M, Goveia MG, Elbasha EH, Dasbach E, Acosta CJ.

BMC Infect Dis. 2018 Mar 7;18(1):119. doi: 10.1186/s12879-018-3034-8. Erratum in: BMC Infect Dis. 2019 Oct 28;19(1):904.

10.

Herpes zoster incidence and cost in patients receiving autologous hematopoietic stem-cell transplant.

Mao J, McPheeters JT, Zhang D, Acosta CJ, Finelli L.

Curr Med Res Opin. 2018 Apr;34(4):741-749. doi: 10.1080/03007995.2017.1384374. Epub 2017 Oct 25.

PMID:
28945107
11.

Herpes Zoster Vaccine Coverage in Older Adults in the U.S., 2007-2013.

Zhang D, Johnson K, Newransky C, Acosta CJ.

Am J Prev Med. 2017 Jan;52(1):e17-e23. doi: 10.1016/j.amepre.2016.08.029. Epub 2016 Oct 26.

12.

Association between work time loss and quality of life in patients with Herpes Zoster: a pooled analysis of the MASTER studies.

Rampakakis E, Stutz M, Kawai K, Tsai TF, Cheong HJ, Dhitavat J, Ortiz-Covarrubias A, Cashat-Cruz M, Monsanto H, Johnson KD, Sampalis JS, Acosta CJ.

Health Qual Life Outcomes. 2017 Jan 18;15(1):11. doi: 10.1186/s12955-017-0588-x.

13.

Energy-based constitutive modelling of local material properties of canine aortas.

Laksari K, Shahmirzadi D, Acosta CJ, Konofagou E.

R Soc Open Sci. 2016 Sep 21;3(9):160365. eCollection 2016 Sep.

14.

Budget-Impact Analysis of Alternative Herpes Zoster Vaccine Strategies: A U.S. HMO Perspective.

Graham J, Mauskopf J, Kawai K, Johnson KD, Xu R, Acosta CJ.

J Manag Care Spec Pharm. 2016 Jul;22(7):872-88. doi: 10.18553/jmcp.2016.22.7.872.

15.

Healthcare resource utilization and costs associated with herpes zoster in the US.

Johnson BH, Palmer L, Gatwood J, Lenhart G, Kawai K, Acosta CJ.

J Med Econ. 2016 Oct;19(10):928-35. doi: 10.1080/13696998.2016.1187150. Epub 2016 May 21.

PMID:
27149530
16.

Annual incidence rates of herpes zoster among an immunocompetent population in the United States.

Johnson BH, Palmer L, Gatwood J, Lenhart G, Kawai K, Acosta CJ.

BMC Infect Dis. 2015 Nov 6;15:502. doi: 10.1186/s12879-015-1262-8.

17.

SURGICAL TREATMENT OF OSTEOARTHRITIS IN HARBOR SEALS (PHOCA VITULINA).

García AR, Contreras GJ, Acosta CJ, Lacave G, Prins P, Marck K.

J Zoo Wildl Med. 2015 Sep;46(3):553-9. doi: 10.1638/2014-0229.1.

PMID:
26352960
18.

A basic dynamic transmission model of Staphylococcus aureus in the US population--ERRATUM.

Hogea C, Van Effelterre T, Acosta CJ.

Epidemiol Infect. 2016 Feb;144(3):670. doi: 10.1017/S0950268815001685. Epub 2015 Jul 27.

PMID:
26211528
19.

Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach.

Dhankhar P, Nwankwo C, Pillsbury M, Lauschke A, Goveia MG, Acosta CJ, Elbasha EH.

Value Health. 2015 Jun;18(4):358-67. doi: 10.1016/j.jval.2015.02.004. Epub 2015 Apr 4.

20.

Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia.

Kawai K, Rampakakis E, Tsai TF, Cheong HJ, Dhitavat J, Covarrubias AO, Yang L, Cashat-Cruz M, Monsanto H, Johnson K, Sampalis JS, Acosta CJ.

Int J Infect Dis. 2015 May;34:126-31. doi: 10.1016/j.ijid.2015.03.022. Epub 2015 Apr 2.

21.

Modeling the durability of ZOSTAVAX® vaccine efficacy in people ≥60 years of age.

Li X, Zhang JH, Betts RF, Morrison VA, Xu R, Itzler RF, Acosta CJ, Dasbach EJ, Pellissier JM, Johnson GR, Chan IS.

Vaccine. 2015 Mar 17;33(12):1499-505. doi: 10.1016/j.vaccine.2014.10.039. Epub 2014 Nov 6.

PMID:
25444784
22.

Herpes Zoster-Related Health Care Resource Utilization in Cancer Patients in 5 European Countries.

Gebremeskel BG, Lopez-Gonzalez L, Patwardhan P, Chin J, Schwalm MS, Acosta CJ, Margolis JM.

Value Health. 2014 Nov;17(7):A684. doi: 10.1016/j.jval.2014.08.2555. Epub 2014 Oct 26. No abstract available.

23.

Herpes zoster-associated severity and duration of pain, health-related quality of life, and healthcare utilization in Taiwan: a prospective observational study.

Tsai TF, Yao CA, Yu HS, Lan CC, Chao SC, Yang JH, Yang KC, Chen CY, White RR, Psaradellis E, Rampakakis E, Kawai K, Acosta CJ, Sampalis JS.

Int J Dermatol. 2015;54(5):529-36. doi: 10.1111/ijd.12484. Epub 2014 Sep 10.

PMID:
25209019
24.

Systematic review of incidence and complications of herpes zoster: towards a global perspective.

Kawai K, Gebremeskel BG, Acosta CJ.

BMJ Open. 2014 Jun 10;4(6):e004833. doi: 10.1136/bmjopen-2014-004833. Review.

25.

Herpes zoster-attributable resource utilization and cost burden in patients with solid organ transplant.

Palmer L, White RR, Johnson BH, Fowler R, Acosta CJ.

Transplantation. 2014 Jun 15;97(11):1178-84. doi: 10.1097/01.tp.0000461121.98312.75.

PMID:
24892964
26.

Evidence-to-policy gap on hepatitis A vaccine adoption in 6 countries: Literature vs. policymakers' beliefs.

Ozawa S, Privor-Dumm LA, Nanni A, Durden E, Maiese BA, Nwankwo CU, Brodovicz KG, Acosta CJ, Foley KA.

Vaccine. 2014 Jul 7;32(32):4089-96. doi: 10.1016/j.vaccine.2014.05.026. Epub 2014 May 15. Review.

27.

Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India.

Ochiai RL, Khan MI, Soofi SB, Sur D, Kanungo S, You YA, Habib MA, Sahito SM, Manna B, Dutta S, Acosta CJ, Ali M, Bhattacharya SK, Bhutta ZA, Clemens JD.

Clin Vaccine Immunol. 2014 May;21(5):661-6. doi: 10.1128/CVI.00791-13. Epub 2014 Mar 5.

28.

Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review.

Kawai K, Preaud E, Baron-Papillon F, Largeron N, Acosta CJ.

Vaccine. 2014 Mar 26;32(15):1645-53. doi: 10.1016/j.vaccine.2014.01.058. Epub 2014 Feb 15. Review.

PMID:
24534737
29.

Vaccines for preventing typhoid fever.

Anwar E, Goldberg E, Fraser A, Acosta CJ, Paul M, Leibovici L.

Cochrane Database Syst Rev. 2014 Jan 2;(1):CD001261. doi: 10.1002/14651858.CD001261.pub3. Review. Update in: Cochrane Database Syst Rev. 2018 May 31;5:CD001261.

PMID:
24385413
30.

A multi-country study of intussusception in children under 2 years of age in Latin America: analysis of prospective surveillance data.

Sáez-Llorens X, Velázquez FR, Lopez P, Espinoza F, Linhares AC, Abate H, Nuñez E, Venegas G, Vergara R, Jimenez AL, Rivera M, Aranza C, Richardson V, Macias-Parra M, Palacios GR, Rivera L, Ortega-Barria E, Cervantes Y, Rüttimann R, Rubio P, Acosta CJ, Newbern C, Verstraeten T, Breuer T.

BMC Gastroenterol. 2013 May 27;13:95. doi: 10.1186/1471-230X-13-95.

31.

A basic dynamic transmission model of Staphylococcus aureus in the US population.

Hogea C, van Effelterre T, Acosta CJ.

Epidemiol Infect. 2014 Mar;142(3):468-78. doi: 10.1017/S0950268813001106. Epub 2013 May 23. Erratum in: Epidemiol Infect. 2016 Feb;144(3):670.

32.

Epidemiology, clinical presentation, and patterns of drug resistance of Salmonella Typhi in Karachi, Pakistan.

Khan MI, Soofi SB, Ochiai RL, Khan MJ, Sahito SM, Habib MA, Puri MK, Von Seidlein L, Park JK, You YA, Ali M, Nizami SQ, Acosta CJ, Sack RB, Clemens JD, Bhutta ZA.

J Infect Dev Ctries. 2012 Oct 19;6(10):704-14. doi: 10.3855/jidc.1967.

33.

Molecular characterization of Staphylococcus aureus in the United States 2004-2008 reveals the rapid expansion of USA300 among inpatients and outpatients.

O'Hara FP, Amrine-Madsen H, Mera RM, Brown ML, Close NM, Suaya JA, Acosta CJ.

Microb Drug Resist. 2012 Dec;18(6):555-61. doi: 10.1089/mdr.2012.0056. Epub 2012 Jul 9.

PMID:
22775581
34.

Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan.

Khan MI, Soofi SB, Ochiai RL, Habib MA, Sahito SM, Nizami SQ, Acosta CJ, Clemens JD, Bhutta ZA; DOMI Typhoid Karachi Vi Effectiveness Study Group.

Vaccine. 2012 Aug 3;30(36):5389-95. doi: 10.1016/j.vaccine.2012.06.015. Epub 2012 Jun 18.

PMID:
22721899
35.

Risk factors associated with typhoid fever in children aged 2-16 years in Karachi, Pakistan.

Khan MI, Ochiai RL, Soofi SB, Von-Seidlein L, Khan MJ, Sahito SM, Habib MA, Puri MK, Park JK, You YA, Ali M, Nizami SQ, Acosta CJ, Bradley-Sack R, Clemens JD, Bhutta ZA.

Epidemiol Infect. 2012 Apr;140(4):665-72. doi: 10.1017/S0950268811000938. Epub 2011 May 31.

PMID:
21676350
36.

Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion.

Mera RM, Suaya JA, Amrine-Madsen H, Hogea CS, Miller LA, Lu EP, Sahm DF, O'Hara P, Acosta CJ.

Microb Drug Resist. 2011 Jun;17(2):321-8. doi: 10.1089/mdr.2010.0193. Epub 2011 Mar 19.

PMID:
21417776
37.

The use of temporary vascular shunts in military extremity wounds: a preliminary outcome analysis with 2-year follow-up.

Borut LT, Acosta CJ, Tadlock LC, Dye JL, Galarneau M, Elshire CD.

J Trauma. 2010 Jul;69(1):174-8. doi: 10.1097/TA.0b013e3181e03e71.

PMID:
20622589
38.

A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.

Sur D, Ochiai RL, Bhattacharya SK, Ganguly NK, Ali M, Manna B, Dutta S, Donner A, Kanungo S, Park JK, Puri MK, Kim DR, Dutta D, Bhaduri B, Acosta CJ, Clemens JD.

N Engl J Med. 2009 Jul 23;361(4):335-44. doi: 10.1056/NEJMoa0807521.

39.

A study of typhoid fever in five Asian countries: disease burden and implications for controls.

Ochiai RL, Acosta CJ, Danovaro-Holliday MC, Baiqing D, Bhattacharya SK, Agtini MD, Bhutta ZA, Canh DG, Ali M, Shin S, Wain J, Page AL, Albert MJ, Farrar J, Abu-Elyazeed R, Pang T, Galindo CM, von Seidlein L, Clemens JD; Domi Typhoid Study Group.

Bull World Health Organ. 2008 Apr;86(4):260-8. Erratum in: Bull World Health Organ. 2015 Apr 1;93(4):284. Bull World Health Organ. 2015 Jun 1;93(6):440.

40.

Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings.

Zhou WZ, Koo HW, Wang XY, Zhang J, Park JK, Zhu F, Deen J, Acosta CJ, Chen Y, Wang H, Galindo CM, Ochiai L, Park T, von Seidlein L, Xu ZY, Clemens JD.

Pediatr Infect Dis J. 2007 Nov;26(11):1001-5.

PMID:
17984806
41.

Comparisons of predictors for typhoid and paratyphoid fever in Kolkata, India.

Sur D, Ali M, von Seidlein L, Manna B, Deen JL, Acosta CJ, Clemens JD, Bhattacharya SK.

BMC Public Health. 2007 Oct 12;7:289.

42.

Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials.

Fraser A, Paul M, Goldberg E, Acosta CJ, Leibovici L.

Vaccine. 2007 Nov 7;25(45):7848-57. Epub 2007 Sep 4. Review.

PMID:
17928109
43.

Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones.

Chau TT, Campbell JI, Galindo CM, Van Minh Hoang N, Diep TS, Nga TT, Van Vinh Chau N, Tuan PQ, Page AL, Ochiai RL, Schultsz C, Wain J, Bhutta ZA, Parry CM, Bhattacharya SK, Dutta S, Agtini M, Dong B, Honghui Y, Anh DD, Canh DG, Naheed A, Albert MJ, Phetsouvanh R, Newton PN, Basnyat B, Arjyal A, La TT, Rang NN, Phuong LT, Van Be Bay P, von Seidlein L, Dougan G, Clemens JD, Vinh H, Hien TT, Chinh NT, Acosta CJ, Farrar J, Dolecek C.

Antimicrob Agents Chemother. 2007 Dec;51(12):4315-23. Epub 2007 Oct 1.

44.

Spatial risk for gender-specific adult mortality in an area of southern China.

Ali M, Jin Y, Kim DR, De ZB, Park JK, Ochiai RL, Dong B, Clemens JD, Acosta CJ.

Int J Health Geogr. 2007 Jul 24;6:31.

45.

Vaccines for preventing typhoid fever.

Fraser A, Goldberg E, Acosta CJ, Paul M, Leibovici L.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001261. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD001261.

PMID:
17636661
46.

The use of typhoid vaccines in Asia: the DOMI experience.

Ochiai RL, Acosta CJ, Agtini M, Bhattacharya SK, Bhutta ZA, Do CG, Dong B, Chen X, Stanton B, Kaljee L, Nyamete A, Galindo CM, von Seidlein L, DeRoeck D, Jodar L, Clemens JD.

Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S34-8.

PMID:
17582567
47.

Geographic analysis of vaccine uptake in a cluster-randomized controlled trial in Hue, Vietnam.

Ali M, Thiem VD, Park JK, Ochiai RL, Canh DG, Danovaro-Holliday MC, Kaljee LM, Clemens JD, Acosta CJ.

Health Place. 2007 Sep;13(3):577-87. Epub 2007 Jan 24.

PMID:
17254831
48.

Optimizing typhoid fever case definitions by combining serological tests in a large population study in Hechi City, China.

Dong B, Galindo CM, Shin E, Acosta CJ, Page AL, Wang M, Kim D, Ochiai RL, Park J, Ali M, Seidlein LV, Xu Z, Yang J, Clemens JD.

Epidemiol Infect. 2007 Aug;135(6):1014-20. Epub 2007 Jan 12.

49.

Trial participation and vaccine desirability for Vi polysaccharide typhoid fever vaccine in Hue City, Viet Nam.

Kaljee LM, Pham V, Son ND, Hoa NT, Thiem VD, Canh DG, Thoa le TK, Ali M, Ochiai RL, Danovaro-Holliday MC, Acosta CJ, Stanton B, Clemens J.

Trop Med Int Health. 2007 Jan;12(1):25-36.

50.

Implementation of good clinical practice guidelines in vaccine trials in developing countries.

Acosta CJ, Galindo CM, Ochiai RL, Danovaro-Holliday MC, Laure-Page A, Thiem VD, Jin Y, Khan MI, Sahito SM, Hamza HB, Park JK, Lee H, Bock H, Elyazeed RA, Albert MJ, Ascaso C, Robles TQ, Ali M, Ngai P, Puri MK, Koo YM, Agtini MD, Soeharno R, Bai-qing D, Kohl D, Xu ZY, Ivanoff B, Jodar L, Pang T, Bhutta Z, Clemens JD.

Vaccine. 2007 Apr 12;25(15):2852-7. Epub 2006 Oct 9.

PMID:
17141380

Supplemental Content

Loading ...
Support Center